+8618709260228
yingjia-victor@yingjia-bio.com
Igbo
English
French
German
Portuguese
Spanish
Russian
Japanese
Korean
Arabic
Irish
Greek
Turkish
Italian
Danish
Romanian
Indonesian
Czech
Afrikaans
Swedish
Polish
Basque
Catalan
Esperanto
Hindi
Lao
Albanian
Amharic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Bulgarian
Cebuano
Chichewa
Corsican
Croatian
Dutch
Estonian
Filipino
Finnish
Frisian
Galician
Georgian
Gujarati
Haitian
Hausa
Hawaiian
Hebrew
Hmong
Hungarian
Icelandic
Igbo
Javanese
Kannada
Kazakh
Khmer
Kurdish
Kyrgyz
Latin
Latvian
Lithuanian
Luxembou..
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Burmese
Nepali
Norwegian
Pashto
Persian
Punjabi
Serbian
Sesotho
Sinhala
Slovak
Slovenian
Somali
Samoan
Scots Gaelic
Shona
Sindhi
Sundanese
Swahili
Tajik
Tamil
Telugu
Thai
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Kinyarwanda
Tatar
Oriya
Turkmen
Uyghur
Ụlọ
Gbasara anyị
Ngwaahịa
Nootropics
Nrụpụta ahụ
Maka Nwoke & Nwanyị
OEM & ODM
API
Akụkọ
Akụkọ ụlọ ọrụ
Akụkọ ụlọ ọrụ
Ajụjụ
Kpọtụrụ anyị
Leave Your Message
Send
Online
Ozi
Ekwentị
:+8618709260228
Email
:yingjia-victor@yingjia-bio.com
WhatsApp
: 0086-13754992613
Ụlọ
Ngwaahịa
API
Ụdị ngwaahịa
Nootropics
Nrụpụta ahụ
Maka Nwoke & Nwanyị
OEM & ODM
API
Ngwaahịa egosipụtara
Mbadamba ụrọ Lenopril na-enye ike njikwa ọbara mgbali na ahụike obi
Telmisartan ka mma antihypertensive na-echebe gbasara akụrụ
Flumazenil A Nhọrọ GABAA Nnabata Onye Mmegide na Ngwa Ọgwụ Ya
Trametinib Kinase Inhibitor na-ezube BRAF V600 Mgbanwe-Ezi Ọrịa Cancer
Dabrafenib Usoro ọgwụgwọ ezubere iche maka ọrịa cancer mutated BRAF
Tirzepatide Dual GLP-1 na GIP Nnabata Agonist maka njikwa ibu na njikwa glycemic.
Cisapride Gastric stimulant maka afọ ntachi na nsogbu mgbaze
YK-11 SARM dị ike maka iwulite akwara, uru ike, na mgbochi Myostatin
Ostarine (MK-2866) SARM dị iche iche maka uto akwara, mfu abụba, na nhazigharị ahụ.
MK-677 Ngwakọta Pụrụ Iche maka Uto Akwara, Ntachi Obi, na Iweghachite
01
02
03
04
05
API
01
Telmisartan ka mma antihypertensive na-echebe gbasara akụrụ
2024-05-24
lee nkọwa
01
Flumazenil A Nhọrọ GABAA Nnabata Onye Mmegide na Ngwa Ọgwụ Ya
2024-05-22
lee nkọwa
01
Trametinib Kinase Inhibitor na-ezube BRAF V600 Mgbanwe-Ezi Ọrịa Cancer
2024-05-19
lee nkọwa
01
Dabrafenib Usoro ọgwụgwọ ezubere iche maka ọrịa cancer mutated BRAF
2024-05-17
lee nkọwa
01
Tirzepatide Dual GLP-1 na GIP Nnabata Agonist maka njikwa ibu na njikwa glycemic.
2024-05-16
lee nkọwa
01
Cisapride Gastric stimulant maka afọ ntachi na nsogbu mgbaze
2024-05-13
lee nkọwa
01
Hormone Growth Human (HGH): Ngwá Ọrụ Dị Ike Maka Ahụ Ike na Mma
2024-05-05
lee nkọwa
01
Eledoisin Versatile Peptide Raw Material Eledoisin Powder
2024-05-03
lee nkọwa
01
Cetrorelix: Onye na-emegide GnRH maka mkpali Ovarian a na-achịkwa yana ọgbaghara na-enwe mmetụta nke homonụ.
2024-05-01
lee nkọwa
01
Bivalirudin: Ihe mgbochi Thrombin na-agbanwe agbanwe maka mgbochi mgbochi dị mma
2024-05-01
lee nkọwa
01
Atosiban na-egbochi ịmụ nwa
2024-04-30
lee nkọwa
01
Vasopressin Multifaceted Hormone na-achịkwa nha nha mmiri
2024-04-30
lee nkọwa
01
Abarelix Gonadotropin dị ike na-ahapụ Hormone antagonist maka ọgwụgwọ ọrịa kansa prostate.
2024-04-30
lee nkọwa
01
Onye nnọchi anya Tropicamide Anticholinergic maka nyocha anya na ọgwụgwọ Tropicamide ntụ ntụ
2024-04-27
lee nkọwa
01
Ndị nnọchi anya Rosuvastatin na-agwọ ọrịa dyslipidemia
2024-04-23
lee nkọwa
Mbụ
Nke gara aga
1
2
3
Osote
Ikpeazụ
Ngụkọta 3